| dc.contributor | | es-ES |
| dc.creator | Florenzano U, Fernando; Departamento de Medicina Oriente, Universidad de Chile.Clínica Las Condes. | |
| dc.date | 2011-10-19 | |
| dc.date.accessioned | 2019-11-11T18:27:27Z | |
| dc.date.available | 2019-11-11T18:27:27Z | |
| dc.identifier | http://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/1730 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/111149 | |
| dc.description | Mortality after myocardial infarction. Thrombolytic therapy or angioplasty. During the recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for thrombolysis, and between 5 to 6 % for angioplasty. The decrease in mortality is related to the implementation of the AUGE program at a national level, initiative than gives to the public the opportunity to receive at least thrombolytic therapy as well as a standarized and rapid diagnosis and treatment for this condition. There is a lack of Outcome Research studies in our country, that would help to take public health decisions such as the use of fibrin-specific agents for early presentation and high risk cases, and a rational system for having better access to primary angioplasty. | es-ES |
| dc.language | es | |
| dc.publisher | Revista Médica de Chile | es-ES |
| dc.relation | http://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1730/3794 | |
| dc.source | Revista Médica de Chile; Vol. 139, núm. 11 (2011): NOVIEMBRE 2011 | es-ES |
| dc.source | 0034-9887 | |
| dc.subject | Angioplasty; Myocardial infarction; Survival rate; Thrombolytic therapy | es-ES |
| dc.title | Mortalidad por infarto del miocardio en chile. Tromboliticos o angioplastia. | es-ES |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | | es-ES |
